Diabetes Plus China Equals Lilly’s Emerging Markets Strategy
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly Emerging Markets President Jacques Tapiero told the Morgan Stanley Healthcare Conference that China is a “must win”, backed by diabetes brands and a near-term pipeline.